Insights Into Treatment Paradigms in Classical Hodgkin Lymphoma (cHL) 2024

Perspectives on existing and emerging treatments for cHL in the first line along with the factors that guide treatment choices

National #1 – May 9, 2024

Faculty Chair

Sarah Rutherford, MD

Weill Cornell Medicine in New York, NY, USA

National #2 – October 22, 2024

Faculty Chair

Alex Herrera, MD

City of Hope in Duarte, CA, USA

National #3 – November 25, 2024

Faculty Chair

Alex Herrera, MD

City of Hope in Duarte, CA, USA

More Information

  • Virtual series
  • National

More Information

  • Virtual series
  • National

More Information

  • Virtual series
  • National

Example Report

Start discovering the insights

View Report

REPORT SNAPSHOT

  • First-Line Treatment of cHL

GEOGRAPHIC REPRESENTATION & CONTENT DEVELOPMENT

  • Data collection is accomplished through use of audience response system questioning and in-depth moderated discussion
  • The group of advisors comprises 10–15 medical oncologists representative of each region

Purchase Report

Thank you for your interest in our insights.

Complete the form below to receive additional information.